Cardiovascular disease, the number one killer in the developed world, presents a special urgency to pharmaceutical and medical device research. Cardiovascular disease treatment has historically been at the forefront of pharmaceutical and medical device convergence; drug-eluting stents set the all-time record for attaining blockbuster status.

Many of our clients' new devices are targeting indications historically treated by drugs and vice versa.
  • Abdominal Aortic Aneurism (AAA)
  • Acute Myocardial Infarction (AMI)
  • Aneurysm
  • Atherectomy
  • Atherosclerosis
  • Atrial Fibrillation
  • Carotid Stenosis
  • Congestive Heart Failure (CHF)
  • Coronary Artery Bypass Grafting (CABG)
  • Deep Vein Thrombosis (DVT)
  • Heart Valve Replacement
  • Hyperlipidemia
  • Hypertension
  • Ischemic Reperfusion Injury
  • Percutaneous Myocardial Revascularization (PMR)
  • Percutaneous Transluminal Coronary Angioplasty (PTCA)
  • Peripheral Vascular Disease (PVD)
  • Pulmonary Embolism (PE)
  • Stable Angina
  • Stroke
  • Transmyocardial Revascularization (TMR)

View our Cardio and Peripheral Vascular Diseases case examples.